- Home
- RMM vs SOPH Comparison
RMM vs SOPH Comparison
Compare RMM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMM
- SOPH
- Stock Information
- Founded
- RMM 2019
- SOPH 2011
- Country
- RMM United States
- SOPH Switzerland
- Employees
- RMM N/A
- SOPH N/A
- Industry
- RMM Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMM Finance
- SOPH Health Care
- Exchange
- RMM Nasdaq
- SOPH Nasdaq
- Market Cap
- RMM 303.8M
- SOPH 247.0M
- IPO Year
- RMM N/A
- SOPH 2021
- Fundamental
- Price
- RMM $15.25
- SOPH $3.13
- Analyst Decision
- RMM
- SOPH Strong Buy
- Analyst Count
- RMM 0
- SOPH 3
- Target Price
- RMM N/A
- SOPH $7.00
- AVG Volume (30 Days)
- RMM 66.5K
- SOPH 30.7K
- Earning Date
- RMM 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- RMM 7.33%
- SOPH N/A
- EPS Growth
- RMM N/A
- SOPH N/A
- EPS
- RMM 0.96
- SOPH N/A
- Revenue
- RMM N/A
- SOPH $64,488,000.00
- Revenue This Year
- RMM N/A
- SOPH $7.34
- Revenue Next Year
- RMM N/A
- SOPH $20.25
- P/E Ratio
- RMM $15.55
- SOPH N/A
- Revenue Growth
- RMM N/A
- SOPH 9.85
- 52 Week Low
- RMM $12.32
- SOPH $2.70
- 52 Week High
- RMM $16.10
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- RMM 37.68
- SOPH 39.02
- Support Level
- RMM $15.33
- SOPH $3.40
- Resistance Level
- RMM $15.85
- SOPH $3.99
- Average True Range (ATR)
- RMM 0.17
- SOPH 0.26
- MACD
- RMM -0.01
- SOPH -0.05
- Stochastic Oscillator
- RMM 4.78
- SOPH 0.00
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.